Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.7B | 7.5B | 8.0B | 7.7B |
Cost of revenue | 6.6B | 6.9B | 6.7B | 6.3B |
Gross profit | 1.1B | 581M | 1.3B | 1.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 784M | 992M | 882M | 923M |
Other operating expenses | 192M | — | 1.1B | 63M |
Operating income | 203M | 740M | -566M | 1.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 88M | 95M | 92M | 30M |
Other income expense | — | — | — | — |
Pretax income | 87M | 602M | -657M | 940M |
Tax provision | 69M | 63M | 105M | 131M |
Net income | 18M | 539M | -762M | 809M |
Basic EPS | 0 | 0.1 | -0.1 | 0.1 |
Diluted EPS | 0 | 0.1 | -0.1 | 0.1 |
Basic average shares | 8B | 8B | 8B | 8B |
Diluted average shares | 8B | 8B | 8B | 8B |
EBITDA | 786M | 1.3B | 54M | 1.5B |
Net income from continuing op. | 87M | 602M | -657M | 940M |
Minority interests | -36M | -20M | -27M | -32M |
Preferred stock dividends | 0 | 0 | 0 | 0 |